Kanoria Chemicals closes trading window till Q1FY27 results
Kanoria Chemicals & Industries has closed its trading window for designated persons from July 1, 2026, until the declaration of its Q1FY27 financial results and two days thereafter. The closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal Code of Conduct. The date for the board meeting to approve the results will be intimated later.

*this image is generated using AI for illustrative purposes only.
Kanoria Chemicals & Industries has closed its trading window for designated persons from July 1, 2026, until the declaration of its financial results for the quarter ended June 30, 2026, and two days thereafter. This measure is intended to prevent insider trading and ensure compliance with regulatory norms during the sensitive period surrounding financial announcements.
The closure follows the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal Code of Conduct designed to regulate, monitor, and report trading by designated persons. During this period, no designated persons are permitted to trade in the company's shares.
The company has stated that the date of the board meeting to approve the financial results for the quarter ended June 30, 2026, will be intimated in due course. The trading window will remain shut until the results are declared and an additional two days have passed.
| Event | Date |
|---|---|
| Trading Window Closure | July 1, 2026 |
| Quarter End | June 30, 2026 |
| Window Reopens | After results declaration + 2 days |
Historical Stock Returns for Kanoria Chemicals & Industries
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.73% | +2.94% | +39.87% | +75.80% | +45.25% | -10.41% |
What market expectations are investors setting for Kanoria Chemicals' Q1 FY27 performance?
How might the extended closure period impact liquidity and trading volume for the company's stock?
Will the upcoming board meeting include any guidance on capex plans or expansion projects for the new fiscal year?































